Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
NHS's 14-Day RSI is ranked better than 63.74% of 1707
companies
in the Asset Management industry
Industry Median: 49.85
vs NHS: 46.27
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Neuberger Berman High Yield Strategies Fund 14-Day RSI Related Terms
NHS vs NRO, TPVG, OPP: 14-Day RSI Comparison
For the Asset Management subindustry, Neuberger Berman High Yield Strategies Fund's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuberger Berman High Yield Strategies Fund 14-Day RSI vs Asset Management Industry
Neuberger Berman High Yield Strategies Fund (AMEX:NHS) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuberger Berman High Yield Strategies Fund (NHS) has a 14-Day RSI of 46.27 as of Jul. 14, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. According to the industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #619 out of 1707 companies in the Asset Management industry, placing it in the top 36.3%.
Is Neuberger Berman High Yield Strategies Fund's 14-Day RSI too high?
Neuberger Berman High Yield Strategies Fund's current 14-Day RSI is 46.27. The Asset Management industry median 14-Day RSI is 49.85. Neuberger Berman High Yield Strategies Fund's value of 46.27 is 7.2% below this industry median. Based on the distribution chart, Neuberger Berman High Yield Strategies Fund ranks #619 out of 1707 companies in the Asset Management industry, which is above the industry midpoint. Overall, Neuberger Berman High Yield Strategies Fund has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neuberger Berman High Yield Strategies Fund's 14-Day RSI compare to NRO and TPVG?
According to the Asset Management industry distribution chart, Neuberger Berman High Yield Strategies Fund ranks #619 out of 1707 companies for 14-Day RSI. This puts Neuberger Berman High Yield Strategies Fund in the upper half of its industry. The industry median 14-Day RSI is 49.85. Neuberger Berman High Yield Strategies Fund's value of 46.27 is 7.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for an Asset Management company?
The median 14-Day RSI among Asset Management companies is 49.85, based on 1,707 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuberger Berman High Yield Strategies Fund's current 14-Day RSI of 46.27 is 7.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Neuberger Berman High Yield Strategies Fund and its competitors. For the Asset Management industry, the median 14-Day RSI is 49.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuberger Berman High Yield Strategies Fund's current 14-Day RSI is 46.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuberger Berman High Yield Strategies Fund stock overvalued right now?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund (NHS) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.23, compared to a current price of $6.21 — trading 14.1% below its estimated fair value. The current 14-Day RSI is 46.27 and 7.2% below the Asset Management industry median of 49.85. Neuberger Berman High Yield Strategies Fund's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Neuberger Berman High Yield Strategies Fund (NHS), the current 14-Day RSI is 46.27 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuberger Berman High Yield Strategies Fund (NHS) Overvalued in 2026?
Based on GuruFocus' analysis, Neuberger Berman High Yield Strategies Fund stock appears to be undervalued.
The current stock price of $6.21 is trading 14.1% below its estimated GF Value™ of $7.23.
GuruFocus considers Neuberger Berman High Yield Strategies Fund to be Modestly Undervalued.
Key valuation signals for NHS:
14-Day RSI: 46.27
GF Value™: $7.23 vs. price of $6.21 (14.1% below fair value)
Industry Position: 7.2% below the Asset Management median (#619 of 1707)
No single metric tells the full story. See the NHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuberger Berman High Yield Strategies Fund Business Description
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
44GF Score
Get the complete analysis for NHS
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHS has been successfully added to your 
